Product correctly added to cart.

discount label
N-Cis-feruloyltyramine
View 3D

Biosynth logo

N-Cis-feruloyltyramine

CAS: 80510-09-4

Ref. 3D-FDA51009

1mgTo inquire
5mgTo inquire
10mgTo inquire
25mgTo inquire
50mgTo inquire
Estimated delivery in United States, on Thursday 22 Aug 2024

Product Information

Name:
N-Cis-feruloyltyramine
Description:

N-Cis-feruloyltyramine is an analog that has shown promising results in inhibiting cancer cell growth. It has been found to be present in urine samples of Chinese cancer patients and has been studied extensively for its potential as an anticancer agent. N-Cis-feruloyltyramine acts as a protein kinase inhibitor, targeting specific kinases that are involved in tumor growth and survival. It induces apoptosis, or programmed cell death, in cancer cells, making it a potential medicinal compound for cancer treatment. With its potent inhibitory effects on cancer cell proliferation and survival, N-Cis-feruloyltyramine may hold great promise as a novel anticancer agent.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
313.3 g/mol
Formula:
C18H19NO4
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-FDA51009 N-Cis-feruloyltyramine

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".